AC-46114 - meglumine-antimoniate | 133-51-7

<p>N-Methylglucamine antimonate is a drug that is used to treat cutaneous leishmaniasis. It is not active against the visceral form of the disease. The drug binds to antimony in a 1:1 stoichiometry and inhibits the polymerase chain reaction (PCR) in the parasite, which prevents DNA replication and transcription. This inhibition leads to cell death and eventual elimination of Leishmania parasites from the host. N-Methylglucamine antimonate is only effective against Leishmania parasites and has no effect on other bacteria or viruses, such as bowel disease. The drug can be given orally or intravenously, but should not be given to patients with bowel diseases because this may lead to intestinal ulceration or perforation.</p>

<p>Applications N-Methylglucamine antimonate (cas# 133-51-7) is a useful research chemical.<br></p>